Skip to Main Content
Diseases of the Cardiovascular System, Phase II-III

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies (CRETE)

What is the purpose of this trial?

The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.

  • Trial with
    National Institutes of Health (NIH)
  • Ages
    17 years and younger
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Edward Vincent Faustino

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    10/03/2023
  • Study HIC
    #2000030683